These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2118259)

  • 1. Evaluation of a colorectal cancer screening program.
    Ehleben CM; Winters PM; Wheeler CJ; Shlaer SM
    Prog Clin Biol Res; 1990; 339():351-60. PubMed ID: 2118259
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors associated with participation in an occupational program for colorectal cancer screening.
    Vernon SW; Acquavella JF; Douglass TS; Hughes JI
    J Occup Med; 1989 May; 31(5):458-63. PubMed ID: 2715855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surveillance and cost-effectiveness of colonoscopy in asymptomatic increased risk subjects of colorectal cancer: Ferrara experience].
    Matarese V; Pezzoli A; Trevisani L; Boccia S; Brancaleoni M; Simone L; Feo C; Gullini S
    Recenti Prog Med; 2004; 95(7-8):352-7. PubMed ID: 15303544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cost-benefit study of a hypertension screening and treatment program at the work setting.
    Hannan EL; Graham JK
    Inquiry; 1978 Dec; 15(4):345-48. PubMed ID: 152293
    [No Abstract]   [Full Text] [Related]  

  • 5. The case for population-based screening for colorectal cancer.
    Schoen RE
    Nat Rev Cancer; 2002 Jan; 2(1):65-70. PubMed ID: 11902587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of promoting colorectal cancer screening on screening utilisation: evaluation of the German Campaign "Aktiv gegen Darmkrebs" (Action against Colorectal Cancer).
    Loss J; Eichhorn C; Nagel E
    Z Gastroenterol; 2006 Nov; 44(11):1127-34. PubMed ID: 17115353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the most cost-effective screening regimen for colon cancer?
    Griffith S; Kane KY
    J Fam Pract; 2001 Jan; 50(1):13. PubMed ID: 11195472
    [No Abstract]   [Full Text] [Related]  

  • 8. [Precautions for intestinal cancer in the workplace. An initiative for secondary prevention in the BASF joint-stock company].
    Webendörfer S; Messerer P; Eberle F; Zober A
    Dtsch Med Wochenschr; 2004 Feb; 129(6):239-43. PubMed ID: 14750049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening of colorectal cancer in Finland and analysis of its cost-effectiveness].
    Malila N; Anttila A; Elovainio L; Hakulinen T; Järvinen H; Paimela H; Pikkarainen P; Rautalahti M; Hakama M
    Duodecim; 2003; 119(12):1115-23. PubMed ID: 12868357
    [No Abstract]   [Full Text] [Related]  

  • 10. [Screening for colorectal cancer: definitely implement].
    Jansen JB
    Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1776. PubMed ID: 18754309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data systems to evaluate colorectal cancer screening practices and outcomes at the population level.
    Carney PA; Hoffman RM; Lieberman DA; Hornbrook MC; Dietrich AJ; Klabunde CN
    Med Care; 2008 Sep; 46(9 Suppl 1):S132-7. PubMed ID: 18725825
    [No Abstract]   [Full Text] [Related]  

  • 12. Colorectal cancer screening: health impact and cost effectiveness.
    Maciosek MV; Solberg LI; Coffield AB; Edwards NM; Goodman MJ
    Am J Prev Med; 2006 Jul; 31(1):80-9. PubMed ID: 16777546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening and surveillance for colorectal cancer.
    Markowitz AJ; Winawer SJ
    Semin Oncol; 1999 Oct; 26(5):485-98. PubMed ID: 10528896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Next Step Trial: impact of a worksite colorectal cancer screening promotion program.
    Tilley BC; Vernon SW; Myers R; Glanz K; Lu M; Hirst K; Kristal AR
    Prev Med; 1999 Mar; 28(3):276-83. PubMed ID: 10072746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the routine, occupation-based gonorrhea and syphilis screening program in Moscow, Russia: an analysis of sexually transmitted infection prevalence and cost-effectiveness.
    Kourbatova EV; Akovbyan VA; Chesson HW; Lytkina IN; Dmitriev GA; Tikhonova LI; Koubanova AA; Petukhova II; Latypova MF; Aboymova OA; Lewis JS; Ryan CA; Shakarishvili A
    Sex Transm Dis; 2008 May; 35(5):453-60. PubMed ID: 18434940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for colorectal cancer: the business case.
    Fletcher RH; Colditz GA; Pawlson LG; Richman H; Rosenthal D; Salber PR
    Am J Manag Care; 2002 Jun; 8(6):531-8. PubMed ID: 12068960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer screening: bring practice in line with the evidence.
    Dis Manag Advis; 2003 Jul; 9(7):96-9, 93. PubMed ID: 12920785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer screening.
    Cher DJ
    J Public Health Med; 1993 Jun; 15(2):211-2. PubMed ID: 8353013
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-effectiveness analysis of two strategies for mass screening for colorectal cancer in France.
    Berchi C; Bouvier V; Réaud JM; Launoy G
    Health Econ; 2004 Mar; 13(3):227-38. PubMed ID: 14981648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.